Orexo AB

Suède


Commandez votre montre hebdomadaire Orexo AB
Quantité totale PI 80
Quantité totale incluant filiales 81 (+ 1 pour les filiales)
Rang # Quantité totale PI 17 277
Note d'activité PI 2,7/5.0    55
Rang # Activité PI 13 050
Symbole boursier
  • C5G (berlin)
  • C5G (frankfurt)
  • ORX (stockholm)
ISIN SE0000736415
Capitalisation 527.9M  (SEK)
Industrie Drug Manufacturers - Specialty & Generic
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

18 9
8 5
20 10
10
 
Dernier brevet 2026 - Pharmaceutical composition for n...
Premier brevet 1997 - Diagnostic preparation for detec...
Dernière marque 2026 - AMORPHOX
Première marque 2006 - SUBLINOX

Filiales

1 subsidiaries with IP (1 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2026 P/S Pharmaceutical preparations. Development of pharmaceutical preparations; research and developmen...
2025 Invention Pharmaceutical composition for nasal delivery. According to the invention, there is provided a s...
P/S Licensing of intellectual property.
Invention New pharmaceutical device for use in intranasal administration. Disclosed is a needle-free appli...
2024 P/S Medical preparation for use as a narcotic antagonist in the treatment of narcotic overdose; Drug ...
Invention Spray-dried compositions comprising cgrp receptor antagonists. According to the invention, there ...
Invention Spray-dried compositions comprising adrenergic receptor modulators. According to the invention, t...
Invention Pharmaceutical composition comprising adrenaline. a pharmaceutically-acceptable carrier material,...
2023 Invention Pharmaceutical composition for nasal delivery. According to the invention, there is provided a so...
Invention Pharmaceutical composition for drug delivery. (b) a pharmaceutically-acceptable carrier material,...
Invention Pharmaceutical composition comprising adrenaline. Compositions are suitable for transmucosal dru...
Invention Pharmaceutical device for use in intranasal administration. (c) at least about 18 hours at above ...
Invention Method of controlling depression in subjects treated for opioid dependence. The present disclosur...
P/S Downloadable therapeutic medical and counseling content, namely, downloadable electronic data and...
2022 Invention Pharmaceutical composition comprising biopharmaceutical drug compounds. According to the inventi...
Invention Pharmaceutical device for use in intranasal administration. According to the invention, there is ...
Invention Pharmaceutical composition comprising atropine. According to the invention, there is provided a s...
Invention Pharmaceutical composition comprising biopharmaceutical drug compounds. According to the inventio...
Invention Pharmaceutical composition comprising adrenaline. According to the invention, there is provided a...
2021 P/S Downloadable, printable therapeutic medical and counseling content, namely, downloadable files co...
P/S Pharmaceutical preparations. Development of pharmaceutical preparations; research and development...
Invention Method of controlling alcohol consumption in subjects treated for opioid dependence. The present ...
Invention New pharmaceutical composition for drug delivery. According to the invention, there is provided a...
P/S Downloadable printable therapeutic medical and counseling content, namely, medical information, m...
P/S Downloadable therapeutic medical and counseling content, namely, downloadable written and graphic...
P/S Downloadable, printable therapeutic medical and counseling content, namely, information, forms, ...
P/S Providing of training and further education in the nature of virtual lectures in the field of med...
2020 P/S Downloadable, therapeutic medical and counseling information in the field of opioid dependence an...
P/S Downloadable, printable therapeutic medical and counseling content, namely, information, forms, i...
P/S Therapeutic services, namely, medical counseling, psychological counseling, medical advice and me...
Invention Pharmaceutical compositions. 8-228-22 fatty acid, such as oleic acid or myristic acid. The dosage...
Invention New pharmaceutical compositions. There are provided solid, pharmaceutically-acceptable compositio...
2019 P/S Advertising; advertising of pharmaceutical products; demonstration of goods for promotional purp...
Invention Pharmaceutical composition for nasal delivery. There is provided a solid pharmaceutical compositi...
P/S Advertising; advertising of pharmaceutical products; demonstration of goods for promotional purpo...
2018 Invention New pharmaceutical compositions. 8-20 inter alia inter alia opioid dependency/addiction and/or pain.
P/S Pharmaceutical preparations for human use, namely, preparations for the treatment of opioid depen...
2017 Invention New alfentanil composition for the treatment of acute pain. There is provided pharmaceutical com...
Invention New abuse-resistant pharmaceutical composition for the treatment of opioid dependence. There is ...
2016 Invention Abuse-resistant pharmaceutical composition for the treatment of opioid dependence. There is prov...
Invention Alfentanil composition for the treatment of acute pain. (c) a compound which is a weak acid, whic...
2015 P/S Pharmaceutical preparations, namely, for the treatment of [ heartburn, migraine, insomnia, urinar...
P/S Pharmaceutical preparations, namely for the treatment of heartburn, migraine, insomnia, urinary ...
Invention Non-abusable pharmaceutical composition comprising opioids. There is provided pharmaceutical com...
2014 Invention New non-abusable pharmaceutical composition comprising opioids. There is provided pharmaceutical...
2013 Invention Pharmaceutical composition for the treatment of acute disorders. A pharmaceutical composition fo...
Invention New sufentanil composition for the treatment of acute pain. There is provided pharmaceutical comp...
Invention New alfentanil composition for the treatment of acute pain. There is provided pharmaceutical comp...
Invention Pharmaceutical formulations useful in the treatment of insomnia. There is provided a formulation ...
P/S Pharmaceutical preparations for human use for the treatment of opioid dependence; pain relief pr...
P/S Pharmaceutical preparations for human use for the treatment of opioid dependence; pain relief pre...
2012 Invention New abuse-resistant pharmaceutical composition for the treatment of opioid dependence. There is p...
Invention Gastric acid secretion inhibiting composition. An oral pharmaceutical dosage form comprises phar...
P/S Pharmaceutical preparations for human use.
2011 Invention Pharmaceutical composition for the treatment of acute disorders. A pharmaceutical composition for...
P/S Pharmaceutical preparations, namely for the treatment of heartburn, migraine, insomnia, urinary i...
2008 P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic...
2006 P/S Pharmaceutical preparations for the prevention and/or treatment of: central nervous system diseas...